Skip to content

AHC International Media Library

Alternating Hemplegia of Childhood and ATP1A3 disorders

  • Interviews
  • Home Videos
  • News
  • Associations
  • Documentaries
  • Presentations
  • Contact
  • About AHCIM
  • Articles
  • Toggle search form

Dr. Mohamad Mikati at the ATP1A3 symposium in Chicago 2018

Posted on November 21, 2018 By siggi

Mohamad A. Mikati M.D., is the Wilburt C. Davison Professor of Pediatrics, Professor of Neurobiology, and Chief of the Division of Pediatric Neurology. Dr. Mikati“s clinical research has centred on characterisation genetics and therapy of pediatric epilepsy and Alternating Hemiplegia of Childhood.
In the laboratory he has elucidated mechanisms of seizure related neuronal injury, particularly those related to the ceramide pathway, demonstrated neuroprotective effects of several agents including erythropoietin and most recently he has concentrated his laboratory research on the pathophysiology of ATP1A3 dysfunction in animal models of Alternating Hemiplegia of Childhood with the eventual goal of hopefully identifying novel therapies for that disorder.

Interviews Tags:AHC, ahc clinic, atp1a3, chicago, Duke, mohamad mikati, professor

Post navigation

Previous Post: Catherine Brownstein – ATP1A3 Symposium in Disease, Chicago 2018
Next Post: Fiorella Gurrieri at the ATP1A3 Symposium in Disease, Chicago 2018

Related Posts

Simon Frost at the ATP1A3 Symposium in Disease – Chicago 2018 Interviews
Fiorella Gurrieri at the ATP1A3 Symposium in Disease, Chicago 2018 Interviews
Habeeb and Abimbola Adeleye Interviews
Dr. Hendrik Rosewich – Assistant Professor Interviews
Filippo Franchini – Father to Lorenzo Interviews
Steven Clapcote – Lecturer in Pharmacology Interviews

Copyright © 2026 AHC International Media Library.

Powered by PressBook Masonry Dark